Propanc Biopharma, Inc. Uncategorized Contracts & Agreements
32 Contracts & Agreements
- Maturity Extension Agreement dated May 10, 2024 (Filed With SEC on May 16, 2024)
- Equity Line Agreement, dated July 20, 2023, by and between the Company and the Investor (Filed With SEC on July 26, 2023)
- Equity Line Agreement, dated November 3, 2022, by and between the Company and the Investor (Filed With SEC on May 15, 2023)
- Consultant Agreement by and between the Company and Paul Patrizio, dated October 1, 2021 (Filed With SEC on November 12, 2021)
- Amended and Restated Director Agreement, by and between the Company and Josef Zelinger, dated August 12, 2021 (Filed With SEC on August 18, 2021)
- Cancellation Agreement, by and between the Company and Dr. Julian Kenyon, dated August 12, 2021 (Filed With SEC on August 18, 2021)
- Cancellation Agreement, by and between the Company and James Nathanielsz, dated August 12, 2021 (Filed With SEC on August 18, 2021)
- Director Agreement, dated December 23, 2020, by and between Propanc Biopharma, Inc. and Josef Zelinger (Filed With SEC on December 30, 2020)
- [Signaturepage follows] (Filed With SEC on August 15, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 28, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 28, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 1, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 8, 2017)
- 40 Wall Street | New York, NY | 10005 p. 347 ###-###-#### | f. 646 ###-###-#### (Filed With SEC on March 21, 2017)
- PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE JANUARY 27, 2018 (Filed With SEC on February 3, 2017)
- PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE DECEMBER 21, 2017 (Filed With SEC on December 30, 2016)
- [PROPANC HEALTH GROUP CORPORATION LETTERHEAD] (Filed With SEC on December 7, 2016)
- JUNIOR SUBORDINATED PROMISSORYNOTE (Filed With SEC on December 7, 2016)
- [Signaturepage follows.] (Filed With SEC on November 23, 2016)
- PROPANC HEALTH GROUP CORPORATION 8% CONVERTIBLE REDEEMABLE JUNIOR SUBORDINATEDNOTE DUE OCTOBER 31, 2017 (Filed With SEC on November 10, 2016)
- ADDITIONAL ISSUANCE AGREEMENT (Filed With SEC on September 16, 2016)
- QUALITY ASSURANCE AGREEMENT (Filed With SEC on August 23, 2016)
- Level2, 555 Riversdale Road, Camberwell, Victoria, 3124, Australia P +61 3 9882 0780 F + 61 3 9882 9969 propanc.com (Filed With SEC on August 4, 2016)
- Level 2, 555 Riversdale Road, Camberwell, Victoria 3124, Australia P +61 3 9882 0780 F + 61 3 9882 9969 propanc.com (Filed With SEC on July 5, 2016)
- AMENDMENTNO. 1 TO EMPLOYMENTAGREEMENT (Filed With SEC on May 16, 2016)
- Dated 20XX PROPANC and [INSERT NAME] _______________________________________________ SCIENTIFIC ADVISORYBOARD MEMBER AGREEMENT _______________________________________________... (Filed With SEC on March 25, 2016)
- DirectorAgreement (Filed With SEC on March 25, 2016)
- EmploymentAgreement (Filed With SEC on March 25, 2016)
- ADDENDUM (Filed With SEC on March 11, 2016)
- SECURITYAGREEMENT (Filed With SEC on September 29, 2015)
- Limited Distributor Deed (Filed With SEC on October 27, 2011)
- EXHIBIT 10.12 UNIVERSITY OF BATH Dated: 18 July 2008 (1) UNIVERSITY OF BATH (2) PROPANC PTY LTD RESEARCH AGREEMENT IN THE DEPARTMENT OF BIOLOGY AND BIOCHEMISTRY RELATING TO... (Filed With SEC on August 18, 2011)
